Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Pozycja w akcjach #827
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Cena akcji
$71.46
Kapitalizacja rynkowa
$29.96B
Zmiana (1 dzień)
-0.04%
Zmiana (1 rok)
-51.01%
Kraj
US
Handel Zoetis Inc. (ZTS)

Kategoria

Healthcare
Historia stopy dywidendy dla Zoetis Inc. (ZTS)
Stopa dywidendy (TTM) dla Zoetis Inc. (symbol akcji: ZTS) na dzień 2023-12-31 wynosi: 0.76%
Średnia stopa dywidendy z ostatnich 5 lat: 0.72%
Historia stopy dywidendy dla Zoetis Inc. (ZTS) od 2009 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
2026 (TTM) 2.84% 167.92%
2024 1.06% 39.47%
2023 0.76% -14.61%
2022 0.89% 117.07%
2021 0.41% -14.58%
2020 0.48% -4.00%
2019 0.50% -15.25%
2018 0.59% 1.72%
2017 0.58% -18.31%
2016 0.71% 1.43%
2015 0.70% 2.94%
2014 0.68% 13.33%
2013 0.60% 46.34%
2012 0.41% -85.41%
2011 2.81% 100.71%
2010 1.40% 105.88%
2009 0.68% 0.00%
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
0.59%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
1.98%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
2.61%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
2.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
2.35%
US